VWA
TNYA icon

VSM Wealth Advisory’s Tenaya Therapeutics TNYA Stock Holding History

VSM Wealth Advisory’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.4K Buy
15,000
+10,000
+200% +$7.38K ﹤0.01% 362
2025
Q4 		$3.56K Buy
+5,000
New +$6.8K ﹤0.01% 394

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VSM Wealth Advisory's TNYA Position: Q1 2026 in Review

VSM Wealth Advisory increased its Tenaya Therapeutics (TNYA) stake by 200% in Q1 2026, buying an estimated $7.38K and bringing the position to 15,000 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

VSM Wealth Advisory first reported a position in TNYA in Q4 2025 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • VSM Wealth Advisory held 15,000 shares of Tenaya Therapeutics worth $10.4K as of Q1 2026.
  • VSM Wealth Advisory bought 10,000 Tenaya Therapeutics shares in Q1 2026, an estimated $7.38K.
  • Tenaya Therapeutics made up ﹤0.01% of VSM Wealth Advisory's portfolio in Q1 2026, its #362 holding.
  • VSM Wealth Advisory first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on VSM Wealth Advisory's 13F filing for Q1 2026, filed 6 May 2026.